TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,519 | -1.5% | 11,669 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $183,320 | -5.1% | 11,669 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $193,220 | +5.1% | 11,724 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $183,760 | +20.1% | 11,779 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $153,000 | -0.6% | 11,776 | +7.1% | 0.00% | 0.0% |
| Q2 2022 | $154,000 | -10.5% | 10,994 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $172,000 | +8.2% | 12,025 | +3.4% | 0.00% | – |
| Q4 2021 | $159,000 | -25.0% | 11,635 | -10.0% | 0.00% | -100.0% |
| Q3 2021 | $212,000 | -1.9% | 12,922 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $216,000 | -10.7% | 12,826 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $242,000 | +3.0% | 13,249 | +2.6% | 0.00% | 0.0% |
| Q4 2020 | $235,000 | -8.2% | 12,913 | -10.1% | 0.00% | 0.0% |
| Q3 2020 | $256,000 | -4.1% | 14,358 | -3.6% | 0.00% | 0.0% |
| Q2 2020 | $267,000 | +25.4% | 14,892 | +6.3% | 0.00% | 0.0% |
| Q1 2020 | $213,000 | -19.9% | 14,012 | +3.9% | 0.00% | 0.0% |
| Q4 2019 | $266,000 | -9.2% | 13,488 | -20.9% | 0.00% | -50.0% |
| Q3 2019 | $293,000 | +7.7% | 17,044 | +10.8% | 0.00% | 0.0% |
| Q2 2019 | $272,000 | -17.6% | 15,384 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $330,000 | – | 16,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |